Treatment of these tumors with anti-VEGF-A combined with a COX 1 inhibitor, salicylic acid, resulted in depletion of FasL expression on tumor endothelial cells, an increase in CD8+ T cells infiltrating the TME, and a reduction in tumor growth (90). This evidence concerns the gene CD8A and neoplasm.